ONYX — Onyx Biotec Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹944.69m
- IN₹1.23bn
- IN₹537.49m
Annual cashflow statement for Onyx Biotec, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IAS | IAS | IAS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 38 | 25.5 | 40.5 |
| Depreciation | |||
| Non-Cash Items | 6.95 | 6.01 | 22.4 |
| Other Non-Cash Items | |||
| Changes in Working Capital | -54.5 | -26.9 | -70.3 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | 4.86 | 19.5 | 15.2 |
| Capital Expenditures | -57.9 | -227 | -32.2 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | 0.098 | 0.651 | 0.748 |
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -57.8 | -227 | -31.5 |
| Financing Cash Flow Items | -5.15 | -5.55 | -21.1 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 52 | 164 | 30.9 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -0.926 | -42.9 | 14.6 |